Alemtuzumab-containing medicinal products 2026 – joint procurement

Summary

The tender concerns recurring deliveries of alemtuzumab-containing medicinal products to three Czech university hospitals (Fakultní nemocnice Olomouc, Hradec Králové Faculty Hospital and Ostrava Faculty Hospital) in accordance with the Czech State Institute for Drug Control (SÚKL) requirements. The contract covers a 48-month supplies period with an estimated total value of CZK 22,746,763 excluding VAT. The award criterion is price, which is the sole criterion; in case of identical bids, a lottery will decide. The bid submission deadline is 29 October 2026 at 10:00 CET. Details regarding tender guarantees and other conditions are laid out in the tender documents.